SEMAGLUTIDE 10 MG

Semaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the GLP-1 hormone to manage type 2 diabetes and promote significant weight loss. By reducing appetite, slowing gastric emptying, and enhancing insulin secretion, it aids in long-term weight management and lowers risks of cardiovascular events. It is sold under brands like Ozempic, Wegovy, and Rybelsus.

Wikipedia +6

Mechanism of Action

• Appetite Suppression: Semaglutide mimics natural GLP-1, targeting brain receptors to increase feelings of fullness and reduce hunger.

• Blood Sugar Regulation: It prompts the pancreas to release more insulin when blood sugar levels are high and prevents the liver from releasing too much glucose

  .

• Gastric Emptying: It slows the rate at which the stomach empties food, which keeps the user feeling full longer.

Common Uses

• Type 2 Diabetes: Used alongside diet and exercise to manage blood sugar.

• Weight Loss/Management: Approved for chronic weight management in patients with obesity or overweight.

• Cardiovascular Health: Reduces the risk of major adverse cardiovascular events (e.g., heart attack, stroke) in patients with diabetes or weight-related conditions.

Administration and Brands

• Ozempic (Injectable): Subcutaneous, once-weekly injection for type 2 diabetes and cardiovascular risk reduction.

• Wegovy (Injectable): Subcutaneous, once-weekly injection specifically approved for chronic weight management.